AlchemLife launches natural immunity booster synthesized from turmeric, pomegranate and ginger
25 Feb 2020 --- Herbal supplement producer AlchemLife has released Phytorelief-CC, a plant-based gummy tablet that offers clinically-backed symptom support for common colds, flu and other seasonal ailments. Synthesized from turmeric, pomegranate and ginger, Phytorelief-CC is touted for its anti-microbial, anti-inflammatory, analgesic and immunity-boosting properties. This launch comes as immunity supplements are steadily in demand, while consumers are increasingly attracted to products based on the Ayurvedic medicinal tradition beaming an all-natural, clean label health halo.
“Your own body is the cure. It simply needs the natural support doctors prescribed for centuries before large-scale pharmaceutical production,” says AlchemLife Chairman Raman Mehta.
Ginger, turmeric and pomegranate are long known to provide a range of health benefits, ranging from anti-inflammation, joint function and mobility support, as well as bolstering heart, mood and cognitive health. In this combination, AlchemLife affirms that these three ingredients work together to help improve immune functions and provide powerful antioxidants to boost the body’s natural defenses against flu and cold viruses.
Phytorelief-CC is a natural ingredient-based supplement to help fight common colds. “There are several over-the-counter options that may help with general health; however, many of these options contain synthetic active ingredients that can lead to other side effects,” the company states. Indeed, consumers are more and more convinced of the positive health effects natural ingredients have in supplementation, especially regarding side effects and high dosages.
Critical clinical backing
Phytorelief-CC is developed using AlchemLife’s proprietary PhytoAdvance technology, which is backed by over 75 years of R&D. The technology is touted as supporting health through the use of synergistic extracts to ensure a high absorption. Phytorelief-CC is also evidence-based and backed by multiple clinical studies, the company states.
Previously speaking with NutritionInsight, Dr. Streeraj Gopi, Chief Scientific Officer at Aurea Biolabs, emphasizes the critical role of (pre-)clinical studies as a strong determinant of the success rate of a product. “Before launching a product, companies always conduct long-term and accelerated stability studies to ensure the shelf life of the product.”
This emphasis on scientific backing is also key for Maja Orešnik, Science & Research Director at PharmaLinea. She highlights that in the past five years, there has been a notable shift in the immunity segment from simple herbal extracts without standardization or direct clinical substantiation into branded, clinically-supported ingredients.
Ginger, turmeric and pomegranate are long touted for their positive health effects.Navigating the natural trend
Industry is on a quest to discover and develop natural-based immunity boosters to appease consumers’ inquisitiveness toward being healthy. Last November, an Integria Healthcare-sponsored study found that a synergistic formula with a specific ratio of Maitake, Reishi and Shiitake mushroom extracts provides an increase in immune stimulation compared to the additive effect of the three individual extracts.
Meanwhile, traditional Ayurvedic herbs, including ginger and turmeric, but also ashwagandha, Indian frankincense and amla, have come to inspire naturality in a wide range of products. Known for significantly reducing pain severity, Arjuna Natural’s BCM-95 (Curcugreen) supplement was not found to incur gastric side effects often associated with the use of non-steroidal anti-inflammatory drugs in a study from last June. Notably, both ashwagandha and ginger are key botanical ingredients in Enovate Biolife’s Lanconone supplement, which can provide joint pain relief within three hours of the first dose.
By Anni Schleicher
To contact our editorial team please email us at editorial@cnsmedia.com

Subscribe now to receive the latest news directly into your inbox.